IP Library Granted Patent US 8,975,018
Granted Patent B2
US 8,975,018 · App. 11/714,077 · Granted Mar 10, 2015

Method of detecting expanded CAG repeat region in spinocerebellar ataxia-2 gene

Inventor: Stefan M. Pulst (Los Angeles, CA)
Assignee: Cedars-Sinai Medical Center
C07K14/47C12Q2600/156C12Q1/6883A01K2217/05
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,975,018
App. No.
11/714,077
Granted
Mar 10, 2015
Kind
B2
Abstract

The present invention provides isolated nucleic acids encoding human SCA2 protein, or fragments thereof, and isolated SCA2 proteins encoded thereby. Further provided are vectors containing invention nucleic acids, probes that hybridize thereto, host cells transformed therewith, antisense oligonucleotides thereto and compositions containing antibodies that specifically bind to invention polypeptides, as well as transgenic non-human mammals that express the invention protein. In addition, methods for diagnosing spinocerebellar Ataxia Type 2 are provided.

Claims (9)

1. A method of detecting an expanded CAG repeat region at a location in a sample from a human subject comprising:

a) contacting a nucleic acid obtained from the subject comprising at least a nucleic acid fragment of SEQ ID NO:2 containing nucleotides 658-723 of SEQ ID NO:2 with a primer comprising SEQ ID NO:6 and a primer comprising SEQ ID NO:7 under conditions suitable to form a detectable amplification product; and

b) evaluating the detectable amplification product to determine if the product contains substantially expanded CAG repeats above normal, wherein a normal number of CAG repeats is 22.

2. The method of claim 1 , wherein said number of CAG repeats is measured by gel electrophoresis.

3. The method of claim 1 , wherein said number of CAG repeats is measured by sequencing said amplification product.

4. The method of claim 1 , wherein the nucleic acid sample is genomic DNA.

5. The method of claim 1 , wherein the nucleic acid sample is cDNA.

6. The method of claim 1 , wherein the number of expanded CAG repeats is between 36 and 52.

7. The method of claim 6 , wherein the number of expanded CAG repeats corresponds to an early onset spinocerebellar ataxia type 2 (SCA2) between age 9 and 60.

Continuity (6)
Continuation 10750323 · Dec 30, 2003
Continuation 09083268 · May 22, 1998
Division 08727084 · Oct 8, 1996
Provisional Application 60017388 · May 8, 1996
Provisional Application 60022207 · Jul 19, 1996
Related Publication 20070224624A1 · Sep 27, 2007